Quinn Grainne
Known title: EVP, Chief Medical OfficerCIK: 0001679915
Associated companies
Transaction History
| PRGO | ▼ Sell | Tax Withholding | 1,170 | $35K | 3/7/2024 | View on chart |
| PRGO | ▲ Buy | Option Exercise | 2,249 | $67K | 3/7/2024 | View on chart |
| PRGO | ▲ Buy | Option Exercise | 1,759 | $49K | 3/6/2024 | View on chart |
| PRGO | ▼ Sell | Tax Withholding | 915 | $26K | 3/6/2024 | View on chart |
| PRGO | ▲ Buy | Option Exercise | 1,583 | $43K | 3/5/2024 | View on chart |
| PRGO | ▼ Sell | Tax Withholding | 824 | $22K | 3/5/2024 | View on chart |
| PRGO | ▼ Sell | Tax Withholding | 4,695 | $128K | 3/5/2024 | View on chart |
| PRGO | ▲ Buy | Grant | 9,028 | $246K | 3/5/2024 | View on chart |
| PRGO | ▲ Buy | Option Exercise | 2,250 | $85K | 3/7/2023 | View on chart |
| PRGO | ▼ Sell | Tax Withholding | 1,170 | $44K | 3/7/2023 | View on chart |
| PRGO | ▼ Sell | Tax Withholding | 2,818 | $109K | 3/3/2023 | View on chart |
| PRGO | ▲ Buy | Option Exercise | 1,052 | $41K | 3/3/2023 | View on chart |
| PRGO | ▼ Sell | Tax Withholding | 548 | $21K | 3/3/2023 | View on chart |
| PRGO | ▲ Buy | Option Exercise | 1,584 | $61K | 3/3/2023 | View on chart |
| PRGO | ▼ Sell | Tax Withholding | 824 | $32K | 3/3/2023 | View on chart |
| PRGO | ▲ Buy | Grant | 5,419 | $210K | 3/3/2023 | View on chart |
| PRGO | ▼ Sell | Open Market | 2,368 | $75K | 12/16/2022 | View on chart |
| PRGO | ▼ Sell | Tax Withholding | 638 | $24K | 3/4/2022 | View on chart |
| PRGO | ▲ Buy | Option Exercise | 1,052 | $39K | 3/4/2022 | View on chart |
| PRGO | ▼ Sell | Tax Withholding | 548 | $20K | 3/4/2022 | View on chart |
| PRGO | ▲ Buy | Option Exercise | 1,584 | $59K | 3/4/2022 | View on chart |
| PRGO | ▼ Sell | Tax Withholding | 824 | $31K | 3/4/2022 | View on chart |
| PRGO | ▲ Buy | Grant | 6,008 | $224K | 3/4/2022 | View on chart |
| PRGO | ▼ Sell | Tax Withholding | 3,125 | $116K | 3/4/2022 | View on chart |
| PRGO | ▲ Buy | Option Exercise | 1,226 | $46K | 3/4/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 14, 2026
Perrigo valuation seen as cheap but burdened by high debt
A recent Seeking Alpha article notes that Perrigo's shares appear cheap compared with peers. The piece highlights that the company carries a sizable debt load, which could limit financial flexibility. This contrast may lead investors to weigh the low valuation against the debt risk when evaluating the company.
Perrigo valuation seen as cheap but burdened by high debt. A recent Seeking Alpha article notes that Perrigo's shares appear cheap compared with peers. The piece highlights that the company carries a sizable debt load, which could limit financial flexibility. This contrast may lead investors to weigh the low valuation against the debt risk when evaluating the company.